Boat, to understand the negative "news" used by Sy
Post# of 148278
Insert-tag-herehttps://emerginggrowth.com/buyersstrike-short-attack-ahead-of-nasdaq-uplisting/
Basically, the two prongs of their attack were picturing MM's surely pre-programmed sales as a negative prediction for the SP and a deliberate misreading of the PR's headline "FDA resumes EIND approval" -- the Sykesians claimed to see that the PR was attempting to bamboozle people into thinking the FDA had given approval for the drug, despite words like "resumes" and "EIND" in the headline.